About
Technology
Issues
FAQ
Links
Official Page
A Phase 1/2 Study of At13387, a Heat Shock Protein 90 (Hsp90) Inhibitor in Combination with Abiraterone Acetate (Aa) and Prednisone (P) in Patients (Pts) with Castration-Resistant Prostate Cancer (Mcrpc) No Longer Responding to Aa
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.